Back to Single Peptide Protocols
Single PeptideHealing & Recovery5 mg vialTwice weeklySubcutaneous

TB-500 (5 mg Vial) Dosage Protocol

Complete TB-500 (Thymosin Beta-4) dosage protocol for the 5 mg vial. Covers loading phase and maintenance dosing.

Vial Size
5 mg
Route
Subcutaneous
Frequency
Twice weekly
Dose Range
1.0–2.5 mg twice weekly

Dosage Schedule

PeriodDose
Loading (Weeks 1–4)2.0–2.5 mg
Maintenance (Weeks 5+)1.0–1.5 mg

Route: Subcutaneous · Frequency: Twice weekly · Cycle: 4–8 weeks

How It Works

TB-500 (Thymosin Beta-4) is a 43-amino-acid peptide that regulates actin polymerization, promotes cell migration, reduces inflammation, and supports wound healing and tissue regeneration.

Potential Benefits

  • Accelerates healing of tendons, ligaments, and muscle tissue.
  • Anti-inflammatory properties in preclinical models.
  • Promotes angiogenesis and cell migration.
  • Randomized placebo-controlled human tolerability data available.

Side Effects & Risks

  • Mild injection-site reactions.
  • Transient fatigue reported in some human studies.
  • Prohibited by WADA in competitive sports.

Important Notes

  • WADA prohibits TB-500 in competitive sports.
  • Rotate injection sites to reduce local irritation.
  • Consult a qualified healthcare provider before use.

Storage Instructions

  • Lyophilized: −20 °C (−4 °F).
  • Once mixed: 2–8 °C; use within 14 days.

References

  1. [1]Goldstein AL et al. Thymosin beta4: a multi-functional regenerative peptide. Expert Opin Biol Ther 2012.View Source
  2. [2]Randomized, placebo-controlled study of IV thymosin beta4 in healthy volunteers. PubMed 2010.View Source

Research & Educational Use Only: This protocol is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any decisions related to peptides or any other compounds.